AlzChem Group マネジメント

マネジメント基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Andreas Niedermaier

最高経営責任者

€1.5m

報酬総額

CEO給与比率	20.9%
CEO在任期間	13.1yrs
CEOの所有権	n/a
経営陣の平均在職期間	7yrs
取締役会の平均在任期間	11.5yrs

経営陣の近況

Recent updates

CEO報酬分析

AlzChem Group の収益と比較して、Andreas Niedermaier の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	€50m
Jun 30 2024	n/a	n/a	€46m
Mar 31 2024	n/a	n/a	€39m
Dec 31 2023	€2m	€315k	€35m
Sep 30 2023	n/a	n/a	€30m
Jun 30 2023	n/a	n/a	€28m
Mar 31 2023	n/a	n/a	€30m
Dec 31 2022	€818k	€315k	€30m
Sep 30 2022	n/a	n/a	€29m
Jun 30 2022	n/a	n/a	€28m
Mar 31 2022	n/a	n/a	€27m
Dec 31 2021	€890k	€300k	€28m
Sep 30 2021	n/a	n/a	€27m
Jun 30 2021	n/a	n/a	€26m
Mar 31 2021	n/a	n/a	€23m
Dec 31 2020	€786k	€300k	€20m
Sep 30 2020	n/a	n/a	€16m
Jun 30 2020	n/a	n/a	€17m
Mar 31 2020	n/a	n/a	€17m
Dec 31 2019	€915k	€260k	€18m
Sep 30 2019	n/a	n/a	€19m
Jun 30 2019	n/a	n/a	€18m
Mar 31 2019	n/a	n/a	€20m
Dec 31 2018	n/a	n/a	€23m
Sep 30 2018	n/a	n/a	€22m
Jun 30 2018	€453k	€110k	€32m
Mar 31 2018	n/a	n/a	€21m
Dec 31 2017	€1m	€220k	€20m

報酬と市場: Andreasの総報酬 ($USD 1.59M ) は、 German市場 ($USD 1.42M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Andreasの報酬は過去 1 年間で 20% 以上増加しました。

CEO（最高経営責任者

Andreas Niedermaier (55 yo)

13.1yrs

在職期間

€1,509,000

報酬

Mr. Andreas Niedermaier has been Chairman of Executive Board & Chief Executive Officer at AlzChem Group AG since July 01, 2019 and has been its Member of Management Board since October 20, 2011. He served...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Andreas Niedermaier	CEO & Chairman of Executive Board	13.1yrs	€1.51m	データなし
Klaus Englmaier	Member of Executive Board & COO	8.8yrs	€1.24m	データなし
Georg Weichselbaumer	Chief Sales Officer & Member of Executive Board	5.3yrs	€1.24m	データなし
Andreas Losle	CFO & Member of Management Board	less than a year	データなし	データなし

7.0yrs

平均在職期間

59yo

平均年齢

経験豊富な経営陣: ACTの経営陣は経験豊富で経験豊富です（平均在職期間は7年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Markus Zöllner	Chairman of the Supervisory Board	15.1yrs	€42.00k	データなし
Martina Heigl-Murauer	Independent Member of the Supervisory Board	8yrs	€24.00k	データなし
Caspar von Schnurbein	Deputy Chairman of the Supervisory Board	8yrs	€32.00k	データなし
Steve Röper	Member of the Supervisory Board	15.1yrs	€22.00k	データなし

11.5yrs

平均在職期間

53.5yo

平均年齢

経験豊富なボード: ACTの取締役会は経験豊富で経験豊富です ( 11.5年の平均在任期間)。

AlzChem Group マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

AlzChem Group AG, Annual General Meeting, May 11, 2023

Recent updates

Third quarter 2024 earnings released: EPS: €1.22 (vs €0.85 in 3Q 2023)

AlzChem Group AG to Report Fiscal Year 2024 Results on Feb 28, 2025

Price target increased by 13% to €71.78

Price target increased by 7.7% to €66.03

Investor sentiment improves as stock rises 20%

Now 23% overvalued

Investor sentiment deteriorates as stock falls 16%

Price target increased by 13% to €61.30

Price target increased by 7.5% to €56.05

Second quarter 2024 earnings released: EPS: €0.71 (vs €0.70 in 2Q 2023)

AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024

Price target increased by 9.4% to €54.05

New minor risk - Share price stability

Price target increased by 15% to €49.40

AlzChem Group AG to Report First Half, 2024 Results on Aug 01, 2024

First quarter 2024 earnings released: EPS: €1.20 (vs €0.76 in 1Q 2023)

Investor sentiment improves as stock rises 17%

Dividend increased to €1.20

AlzChem Group AG to Report Q3, 2024 Results on Nov 07, 2024

Price target increased by 7.9% to €37.35

Price target increased by 7.9% to €35.60

Price target increased by 9.1% to €34.63

AlzChem Group AG to Report Q1, 2024 Results on Apr 30, 2024

Price target increased by 9.3% to €33.00

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: €0.85 (vs €0.58 in 3Q 2022)

AlzChem Group AG to Report Fiscal Year 2023 Results on Mar 01, 2024

AlzChem Group AG to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment improves as stock rises 17%

New minor risk - Financial position

Second quarter 2023 earnings released: EPS: €0.71 (vs €0.95 in 2Q 2022)

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG to Report First Half, 2023 Results on Aug 03, 2023

Upcoming dividend of €1.05 per share at 5.5% yield

Price target increased by 8.7% to €29.58

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improved over the past week

AlzChem Group AG, Annual General Meeting, May 11, 2023

Price target decreased to €26.05

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG to Report Fiscal Year 2022 Final Results on Feb 28, 2023

Price target decreased to €26.05

AlzChem Group AG provides sales guidance For the fiscal year 2022

Second quarter 2022 earnings released: EPS: €0.95 (vs €0.90 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

AlzChem Group AG Approves Dividend

Upcoming dividend of €1.00 per share

AlzChem Group AG Increasing Its Sales Forecast for the Fiscal Year 2022

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

AlzChem Group AG Proposes Dividend for the Year 2021

Third quarter 2021 earnings released: EPS €0.46 (vs €0.37 in 3Q 2020)

Price target increased to €32.25

Second quarter 2021 earnings released: EPS €0.66 (vs €0.66 in 2Q 2020)

AlzChem Group AG Revises Earnings Guidance for the Year 2021

AlzChem Group AG Resolves Dividend, Payable on May 18, 2021

First quarter 2021 earnings released

Upcoming dividend of €0.77 per share

AlzChem Group AG Revises Earnings Guidance for 2021

Full year 2020 earnings released: EPS €1.94 (vs €1.77 in FY 2019)

AlzChem Group AG Provides Consolidated Sales Guidance for the Full Year 2021

AlzChem Group AG Proposes Dividend for 2020

New 90-day high: €24.50

AlzChem Group AG to Report Fiscal Year 2020 Results on Mar 19, 2021

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: EPS €0.37

AlzChem Group AG Expands Nitrile Production by 50%

New 90-day low: €17.50

AlzChem Group AG Revises Consolidated Sales Guidance for the Fiscal Year 2020

AlzChem Group AG to Report First Half, 2021 Results on Aug 05, 2021

AlzChem Group AG to Report Q1, 2021 Results on May 06, 2021

Price target raised to €28.50

New 90-day high - €22.70

Earnings released

CEO報酬分析

マネジメント基準チェック /34